← Back to Search

Cognitive Behavior Therapy for Small Cell Lung Cancer

N/A

Waitlist Available

Led By Barbara Andersen, PhD

Research Sponsored by Ohio State University Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 month post-treatment

Awards & highlights

Study Summary

This trial is testing whether a form of cognitive-behavioral therapy can help reduce the intensity and frequency of dyspnea in patients with lung cancer.

Eligible Conditions

Small Cell Lung Cancer
Non-Small Cell Lung Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 month post-treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 month post-treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 month post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in acceptability of Take a Breath (TAB)

Change in dyspnea severity using the American Thoracic Society Dyspnea Questionnaire

Change in shortness of breath

+2 more

Secondary outcome measures

Catastrophic thoughts related to dyspnea

Mood disturbance

Physical activity using International Physical Activity Questionnaire (IPAQ)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (TAB)Experimental Treatment2 Interventions

Patients participate in 4 weekly TAB in-person or video conference sessions over 1 hour each that provide them with skills to cope with their dyspnea. Patients also receive treatment handouts, a CD with an audio file with instructions for progressive muscle relaxation, and a pulse oximeter. Patients may receive additional support calls over 10-15 minutes from the TAB provider within 1 week following each session.

Group II: Arm II (usual care)Active Control2 Interventions

Patients receive usual management of dyspnea from the treating physician.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cognitive Behavior Therapy

2010

Completed Phase 3

~2630

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor

320 Previous Clinical Trials

290,121 Total Patients Enrolled

Barbara Andersen, PhDPrincipal InvestigatorOhio State University Comprehensive Cancer Center

3 Previous Clinical Trials

100 Total Patients Enrolled

Media Library

Cognitive Behavior Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05304793 — N/A

Small Cell Lung Cancer Research Study Groups: Arm I (TAB), Arm II (usual care)

Small Cell Lung Cancer Clinical Trial 2023: Cognitive Behavior Therapy Highlights & Side Effects. Trial Name: NCT05304793 — N/A

Cognitive Behavior Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05304793 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants is the research team recruiting for this experiment?

"Affirmative. Clinicaltrials.gov has information indicating that this medical test is actively seeking volunteers, with the initial posting on July 1st 2020 and latest update being on March 22nd 2022. Currently, 40 people are required to be recruited from a single trial site."

Answered by AI

Are recruiting efforts currently underway for this clinical experiment?

"Affirmative. According to the information located on clinicaltrials.gov, this research is actively recruiting participants as of March 22nd 2022 with a study initiation date of July 1st 2020. 40 volunteers are needed at one medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer

Barbara Andersen 2020. "Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05304793.